Who are Sun Genomics's investors?

Sun Genomics's investors include Orion Capital Asia, Pangaea Ventures, K3 Ventures, Danone Manifesto Ventures, SOSV, Nascita Ventures.

When was Sun Genomics founded?

Sun Genomics was founded in 2016.

Where is Sun Genomics headquartered?

Sun Genomics is headquartered in San Diego, California, United States.

What industry is Sun Genomics in?

Sun Genomics operates in Biotech, Healthcare.

How many employees does Sun Genomics have?

Sun Genomics has 11-50 employees.

Sun Genomics

Personalized probiotics powered by your microbiome

San Diego, United States · Founded 2016

Biotech

Healthcare

Headquarters: San Diego, California
Employees: 11–50
Founded: 2016
Business Model: B2C

Website: sungenomics.com
Last Round: Series ASep 2020
Rounds: 2

About

Sun Genomics (operating as Floré) is a San Diego-based biotech company that creates fully personalized probiotic formulas based on individual gut microbiome analysis. Customers submit a stool sample, which is analyzed using DNA sequencing to map their unique gut microbiome composition. The company then formulates a custom probiotic tailored to address specific imbalances and health goals. Founded in 2016 by Sunny Jain, Sun Genomics expanded its product line to include customized multivitamins and other precision nutritional supplements. The company participates in functional medicine conferences and is backed by IndieBio, the early-stage biotech accelerator.

Summary

Sun Genomics is a Biotech company based in San Diego, United States, founded in 2016. Its most recent funding was a Series A round in Sep 2020. Investors include Orion Capital Asia, Pangaea Ventures and K3 Ventures.